GB1403900A - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- GB1403900A GB1403900A GB5049572A GB5049572A GB1403900A GB 1403900 A GB1403900 A GB 1403900A GB 5049572 A GB5049572 A GB 5049572A GB 5049572 A GB5049572 A GB 5049572A GB 1403900 A GB1403900 A GB 1403900A
- Authority
- GB
- United Kingdom
- Prior art keywords
- ion source
- pharmaceutical composition
- nov
- active ingredients
- magnesium ion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 abstract 2
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 229910001425 magnesium ion Inorganic materials 0.000 abstract 2
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 abstract 1
- 208000000913 Kidney Calculi Diseases 0.000 abstract 1
- 206010029148 Nephrolithiasis Diseases 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008203 oral pharmaceutical composition Substances 0.000 abstract 1
- 239000008024 pharmaceutical diluent Substances 0.000 abstract 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HUCI1185A HU165181B (enrdf_load_stackoverflow) | 1971-11-08 | 1971-11-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1403900A true GB1403900A (en) | 1975-08-28 |
Family
ID=10994422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB5049572A Expired GB1403900A (en) | 1971-11-08 | 1972-11-02 | Pharmaceutical composition |
Country Status (9)
| Country | Link |
|---|---|
| AT (1) | AT332531B (enrdf_load_stackoverflow) |
| CA (1) | CA978479A (enrdf_load_stackoverflow) |
| CS (1) | CS217603B1 (enrdf_load_stackoverflow) |
| DD (1) | DD100631A1 (enrdf_load_stackoverflow) |
| DE (1) | DE2252665A1 (enrdf_load_stackoverflow) |
| GB (1) | GB1403900A (enrdf_load_stackoverflow) |
| HU (1) | HU165181B (enrdf_load_stackoverflow) |
| IL (1) | IL40685A (enrdf_load_stackoverflow) |
| SU (1) | SU1009467A1 (enrdf_load_stackoverflow) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4960108A (en) * | 1987-08-28 | 1990-10-02 | Leopold & Co. Chem. Pharm. Fabrik Gesellschaft M.B.H. | Laser-induced shockwave lithotripsy |
| JPH03223228A (ja) * | 1989-02-07 | 1991-10-02 | Misson Pharmacal Co Inc | 医薬組成物 |
| WO2009143021A1 (en) * | 2008-05-22 | 2009-11-26 | Bristol-Myers Squibb Company | Method for treating and preventing kidney stones employing an sglt2 inhibitor and composition containing same |
| JP2016513474A (ja) * | 2013-03-15 | 2016-05-16 | ニューヨーク ユニバーシティ | クエン酸塩を含有した飲料 |
| US9636304B2 (en) | 2010-11-18 | 2017-05-02 | Advicenne | Pharmaceutical composition comprising citrate and bicarbonate salts, and use thereof for treating cystinuria |
| US9782352B2 (en) | 2010-11-18 | 2017-10-10 | Advicenne | Pharmaceutical composition comprising Krebs cycle precursor salt, in particular citrate salt, and use thereof as a medicament |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2826642C2 (de) | 1978-06-19 | 1987-04-23 | Dr. Madaus & Co, 5000 Köln | Orales Urolithiasismittel |
| DE3046580A1 (de) * | 1980-12-11 | 1982-07-01 | Leskovar, Peter, Dr.-Ing., 8000 München | Harnsteinaufloesende mittel |
| CA1326040C (en) * | 1989-11-16 | 1994-01-11 | Neill B. Walsdorf | Magnesium-potassium citrate |
| DE4409949C2 (de) * | 1994-03-23 | 1996-11-21 | Madaus Ag | Verwendung von Calcium-Alkalicitraten zur Prophylaxe und Behandlung degenerativer Erkrankungen des Knochengerüstes |
| DE10028167B4 (de) * | 2000-06-09 | 2004-02-19 | Storch, Rüdiger, Dr. | Verwendung von Calciumsalzen zur Entgegenwirkung der Bildung von Oxalatharnsteinen |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3328304A (en) * | 1964-07-31 | 1967-06-27 | Guardian Chemical Corp | Chelating agents and methods for their manufacture |
| FR2019261A1 (en) * | 1969-03-19 | 1970-07-03 | Melon Jean Marie | Treatment of oxalic lithiase with succinic - acid and its derivs |
-
1971
- 1971-11-08 HU HUCI1185A patent/HU165181B/hu unknown
-
1972
- 1972-10-27 IL IL40685A patent/IL40685A/en unknown
- 1972-10-27 DE DE2252665A patent/DE2252665A1/de active Granted
- 1972-10-31 AT AT925372A patent/AT332531B/de not_active IP Right Cessation
- 1972-11-02 DD DD166641A patent/DD100631A1/xx unknown
- 1972-11-02 GB GB5049572A patent/GB1403900A/en not_active Expired
- 1972-11-04 SU SU721846969A patent/SU1009467A1/ru active
- 1972-11-07 CA CA155,789A patent/CA978479A/en not_active Expired
- 1972-11-08 CS CS727556A patent/CS217603B1/cs unknown
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4960108A (en) * | 1987-08-28 | 1990-10-02 | Leopold & Co. Chem. Pharm. Fabrik Gesellschaft M.B.H. | Laser-induced shockwave lithotripsy |
| JPH03223228A (ja) * | 1989-02-07 | 1991-10-02 | Misson Pharmacal Co Inc | 医薬組成物 |
| JP2545479B2 (ja) | 1989-02-07 | 1996-10-16 | ミッション ファーマカル カンパニー，インコーポレーテッド | 医薬組成物 |
| WO2009143021A1 (en) * | 2008-05-22 | 2009-11-26 | Bristol-Myers Squibb Company | Method for treating and preventing kidney stones employing an sglt2 inhibitor and composition containing same |
| US8603989B2 (en) | 2008-05-22 | 2013-12-10 | Bristol-Myers Squibb Company | Method for treating and preventing kidney stones employing an SGLT2 inhibitor and composition containing same |
| US9636304B2 (en) | 2010-11-18 | 2017-05-02 | Advicenne | Pharmaceutical composition comprising citrate and bicarbonate salts, and use thereof for treating cystinuria |
| US9782352B2 (en) | 2010-11-18 | 2017-10-10 | Advicenne | Pharmaceutical composition comprising Krebs cycle precursor salt, in particular citrate salt, and use thereof as a medicament |
| JP2016513474A (ja) * | 2013-03-15 | 2016-05-16 | ニューヨーク ユニバーシティ | クエン酸塩を含有した飲料 |
| US10258645B2 (en) | 2013-03-15 | 2019-04-16 | New York University | Citrate containing beverage |
Also Published As
| Publication number | Publication date |
|---|---|
| CS217603B1 (en) | 1983-01-28 |
| AT332531B (de) | 1976-10-11 |
| DE2252665A1 (de) | 1973-05-10 |
| IL40685A0 (en) | 1972-12-29 |
| HU165181B (enrdf_load_stackoverflow) | 1974-07-27 |
| ATA925372A (de) | 1976-01-15 |
| IL40685A (en) | 1976-08-31 |
| CA978479A (en) | 1975-11-25 |
| DE2252665C2 (enrdf_load_stackoverflow) | 1987-09-10 |
| SU1009467A1 (ru) | 1983-04-07 |
| DD100631A1 (enrdf_load_stackoverflow) | 1973-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1325688A (en) | Self propelled harvesting machine | |
| GB1403900A (en) | Pharmaceutical composition | |
| SE8901041L (sv) | Antitrombotiska farmaceutiska preparat samt foerfarande foer deras framstaellning | |
| GB1388358A (en) | Taste-improving formulations of oral penicillins | |
| GB1464200A (en) | Pharmaceutical composition | |
| GB1341794A (en) | Medicament for the treatment of hepatic disorders | |
| CA936533A (en) | 5-aryl-2,3-dihydro-2,2(or 3,3) dimethyl-5h-imidazo(2,1-a) isoindol-5-ols and 2(4,4(5,5) dimethyl-2-imidazolin-2-yl) bensophenone acid addition salts and processes for their preparation | |
| GB1318169A (en) | Moulded pharmaceutical compositions | |
| GB1250725A (enrdf_load_stackoverflow) | ||
| ES421299A1 (es) | Un metodo de preparacion de un vehiculo farmaceutico. | |
| IE34609B1 (en) | Antineoplastic therapeutic compositions | |
| CA1008461A (en) | 3,4-dihydroxyphenyl-alamines as active ingredients of antioxidant compositions | |
| CA960655A (en) | N(6)-aralkyl adenosine derivatives, process for their preparation and pharmaceutical compositions containing the same | |
| GB1287433A (en) | Pharmaceutical compositions | |
| ES415670A1 (es) | Procedimiento para la preparacion de diclorobenzaldehido- xincarbonatos. | |
| GB1353834A (en) | Benzenesulphonamides | |
| GB1449043A (en) | Treatment of asthma | |
| CA953715A (en) | N(6)-(2,5-dimethylbenzyl)-2-chloroadenosine derivatives, process for their preparation and pharmaceutical compositions containing the same | |
| GB1449441A (en) | Agnets for lowering the lipid level in plasma | |
| GB1264695A (enrdf_load_stackoverflow) | ||
| CA945544A (en) | 16-METHYLENE-9.beta., 10.alpha.-STEROID COMPOUNDS, PHARMACEUTICAL PREPARATIONS WHICH CONTAIN THE NOVEL COMPOUNDS AS ACTIVE INGREDIENTS, AND METHODS OF PRODUCING THE SAID COMPOUNDSAND PREPARATIONS | |
| GB1421323A (en) | Pharmaceutical compositions containing sodium tri-n-propylacetate | |
| CA849567A (en) | Alpha-(2-hydroxy-3,5,6-trichloro)-phenylglycol acid and biocidal compositions | |
| GB1296625A (enrdf_load_stackoverflow) | ||
| CA951310A (en) | METHOD FOR THE PREPARATION OF 2.alpha.,3.alpha.-EPITHIO-5.alpha.-STEROIDS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| 435 | Patent endorsed 'licences of right' on the date specified (sect. 35/1949) | ||
| PE20 | Patent expired after termination of 20 years |